Axolotl Biologix launches new regenerative fluid syringe for orthopedic wound care: 3 details

Axolotl Biologix released the Axolotl Shot, a syringe preloaded with ambient temperature regenerative fluid that physicians can apply to patients during same-day, outpatient visits.

Advertisement

Here are three details:

1. Axolotl Shot comprises regenerative fluid derived from the amniotic components of donor tissue placenta.

2. It is designed to promote regeneration and repair patients’ damaged or degenerated tissues.

3. The shot is preloaded in 1 milliliter and 2 milliliter volumes and can be stored at room temperature.

More articles on biologics:
Center for Neurosciences, Orthopaedics & Spine using plasma injections to treat joint pain
DiscGenics gets green light for clinical trial in Japan: 5 details
Kuros Biosciences receives FDA clearance to extend MagnetOs Putty applications: 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.